Moderna's cod vaccine

EMA COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE ISSUES

eAwaz Medicine

CAMBRIDGE – Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending a variation to the marketing authorization (CMA) to include a 25 µg two-dose series of Spikevax (mRNA-1273) for active immunization to prevent coronavirus disease 2019 …

Moderna Spikevax

CHMP RECOMMENDS MODERNA COVID-19 BOOSTER IN ADOLESCENTS 

eAwaz Medicine

CAMBRIDGE – Moderna, Inc, (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending a variation to the conditional marketing authorization (CMA) to include a booster dose of Spikevax, the Company’s COVID-19 vaccine, at the 50 µg …